Alvotech (ALVOW) Other Non-Current Assets (2020 - 2025)
Alvotech (ALVOW) reported Other Non-Current Assets of $8.6 million for Q4 2025, up 137.29% on a YoY basis from $3.6 million in Q4 2024, and up 81.47% quarter-over-quarter from $4.7 million in Q3 2025.
Alvotech (ALVOW) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Alvotech has reported Other Non-Current Assets for 6 years, with the latest figure at $8.6 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 137.29% year-over-year to $8.6 million; the trailing twelve-month figure through Dec 2025 stood at $8.6 million (up 137.29% YoY), and the FY2025 full-year result was $8.6 million, up 137.29% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $8.6 million, up from $4.7 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $26.1 million in Q4 2023, with the low at $3.6 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $15.8 million across 5 years, with a median of $17.5 million in 2021.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 149.7% — and 2024, when it plunged 86.17%.
- Alvotech's Other Non-Current Assets stood at $10.1 million in 2021, then surged by 149.7% to $25.2 million in 2022, then gained by 3.75% to $26.1 million in 2023, then sank by 86.17% to $3.6 million in 2024, then surged by 137.29% to $8.6 million in 2025.
- The last three Other Non-Current Assets figures came in at $8.6 million (Q4 2025), $4.7 million (Q3 2025), and $4.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Alvotech | - | - | -22.39 Mn | 8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.58 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 9.52 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Mar 31, 2024 | 25.00 Mn |
| Dec 31, 2023 | 26.13 Mn |
| Jun 30, 2023 | 25.19 Mn |
| Mar 31, 2023 | 25.19 Mn |
| Dec 31, 2022 | 25.19 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 10.09 Mn |
| Dec 31, 2020 | 10.09 Mn |